TITLE

Molecular Pathogenesis of Cholestasis

AUTHOR(S)
Elias, E.
PUB. DATE
October 2004
SOURCE
Gut;Oct2004, Vol. 53 Issue 10, p1547
SOURCE TYPE
Review
DOC. TYPE
Book Review
ABSTRACT
Reviews the book "Molecular Pathogenesis of Cholestasis," by M. Trauner and P.L.M. Jansen.
ACCESSION #
14674413

 

Related Articles

  • Cholestasis in patients with acquired immunodeficiency... Liu, Katherine J.M.; Atten, Mary Jo // American Surgeon;Jun1997, Vol. 63 Issue 6, p519 

    Reviews cholestasis in patients with acquired immunodeficiency syndrome (AIDS). Underlying causes of cholestasis; Predominant findings in patients with AIDS and hepatocellular diseases; Acalculous cholecystitis described; Two disease entities of abnormalities of intraheptic/extraheptic duct.

  • Everolimus.  // Reactions Weekly;6/19/2010, Issue 1306, p23 

    The article describes the cases of two patients who developed cholestasis after receiving everolimus.

  • Intrahepatic Cholestasis. Greenstein, Adrian J. // American Journal of Gastroenterology;Sep1976, Vol. 66 Issue 3, p316 

    Reviews the book "Intrahepatic Cholestasis," edited by P. Gentilini, U. Teodori, S. Gorini and H. Popper.

  • Corrigendum.  // Journal of Clinical Investigation;Jul2004, Vol. 114 Issue 1, p142 

    Presents a correction to the article "Cathepsin B Inactivation Attenuates Hepatic Injury and Fibrosis During Cholestasis" that was previously published in the vol. 112, 2003 issue of the "Journal of Clinical Investigation."

  • Antidepressant induced cholestasis: hepatocellular redistribution of multidrug resistant protein (MRP2). Milkiewicz, P.; Chilton, A.P.; Hubscher, S.G.; Elias, E. // Gut;Feb2003, Vol. 52 Issue 2, p300 

    Background: We report two cases of antidepressant induced cholestasis. Case reports: We describe the first reported case of acute cholestasis due to citalopram (selective serotonin reuptake inhibitor) occurring in a patient who also experienced obstetric cholestasis in association with each of...

  • Hepatoprotection with tauroursodeoxycholate and β muricholate against tauroilthocolate induced cholestasis: involvement of signal transduction pathways. Milkiewicz, P.; Roma, M.G.; Elias, E.; Coleman, R. // Gut;Jul2002, Vol. 51 Issue 1, p113 

    Background: Tauroursodeoxycholate (TUDC) provides partial protection against taurolithocholate (TLC) induced cholestasis, possibly by inducing a signalling cascade activating protein kinase C (PKC). The potential protective effects of β muricholic acid (β-MC), another 7-β-hydroxylated...

  • Arteriohepatic Dysplasia: A Benign Syndrome of Intrahepatic Cholestasis with Multiple Organ Involvement. Riely, Carolyn A.; Cotlier, Edward; Jensen, Pamela S.; Klatskin, Gerald // Annals of Internal Medicine;Oct79, Vol. 91 Issue 4, p520 

    Presents clinical reports of patients with arteriohepatic dysplasia or Alagille's syndrome, an intrahepatic cholestatic syndrome. Information on intrahepatic cholestasis; Background on the patients; Results of the clinical reports.

  • Sepsis and cholestasis. Paton, Alex // British Medical Journal (Clinical Research Edition);10/6/1984, Vol. 289 Issue 6449, p857 

    Examines the association of cholestasis with sepsis. Cause of cholestasis; Symptoms on the development of sepsis in patients with cholestasis; Sites common in sepsis infection.

  • Lamotrigine/quetiapine/zopiclone.  // Reactions Weekly;9/25/2010, Issue 1320, p32 

    The article describes the case of a 36-year-old man who developed cholestasis leading to hypercholesterolaemia and pseudoponatraemia while receiving quetiapine, lamotrigine and zopiclon for bipolar affective disorder.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics